#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant melanoma Astrocytoma Pyruvate kinase deficiency anaemia Acquired C1 inhibitor deficiency B-cell small lymphocytic lymphoma Staphylococcal infection Intracranial calcification Angiosarcoma Choroid melanoma Non-renal cell carcinoma of kidney Rectal cancer Mantle cell lymphoma recurrent Paget's disease of the vulva Von Hippel-Lindau disease Restless legs syndrome More trials…

    Learn about Rare Diseases

    Stevens-Johnson syndrome – Trials in Disease Ehlers-Danlos syndrome – Treatment Ewing’s sarcoma recurrent – Trials in Disease Adrenogenital syndrome – Life with Disease Haemophagocytic lymphohistiocytosis Nodal marginal zone B-cell lymphoma – Life with Disease Osteosarcoma recurrent – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Primary immunodeficiency syndrome – Treatment Progressive supranuclear palsy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Peginterferon Beta-1A Tegoprubart Pitavastatin Calcium Acoramidis Hydrochloride Gad20-209-Fsp-A1 Fipaxalparant AZD6234 Milademetan Tezepelumab Flecainide Lenzumestrocel Acalabrutinib Ertapenem Sodium Florquinitau (18F) Xenon Tofacitinib Citrate Warfarin Sodium [11C]Az14193391 RNK001 Sodium Acetate Trihydrate More therapies…

    Learn about Your Condition

    Corneal graft rejection Familial mediterranean fever Cartilage injury Haemoglobinuria Metastatic neoplasm Myocarditis post infection Angiosarcoma recurrent Cardiac sarcoidosis Neck pain Renal failure Hernia repair Oral neoplasm Cancer pain Injury Red blood cell abnormality More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pleomorphic liposarcoma

  • Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ttf-Ngr
    Germany
  • Study on the Effectiveness and Safety of INT230-6 (Vinblastine Sulfate, Cisplatin) for Adults with Metastatic Soft Tissue Sarcomas

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dedifferentiated liposarcoma
    • Leiomyosarcoma
    • Malignant fibrous histiocytoma
    Investigated Drugs:
    • Pazopanib
    • Vinblastine Sulfate
    • Trabectedin
    France Germany Italy Poland Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!